![Cecilia Hofvander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cecilia Hofvander
Investor Relations Kontakt bei
BIOINVENT INTERNATIONAL AB
Profil
Cecilia Hofvander is currently Vice President-Investor Relations at BioInvent International AB since 2021.
Former positions include Director-Investor Relations & Communications at Abliva AB, Assistant Director-Investor Relations at Active Biotech AB, and Communications Director at Alligator Bioscience AB from 2017 to 2021.
Education includes an undergraduate degree from the University of Lund.
Aktive Positionen von Cecilia Hofvander
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Investor Relations Kontakt | 01.02.2021 |
Ehemalige bekannte Positionen von Cecilia Hofvander
| Unternehmen | Position | Ende |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Investor Relations Kontakt | 01.02.2021 |
| ABLIVA AB | Investor Relations Kontakt | - |
| ACTIVE BIOTECH AB | Public Communications Contact | - |
Ausbildung von Cecilia Hofvander
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
